Abbott CEO "fully confident" in future pharma spin-out chief, despite resume fuss
Abbott (NYSE:ABT) chairman & CEO Miles White said he’s "fully confident" in Richard Gonzalez as the new head of the company’s AbbVie pharmaceutical spin-out, in spite of the ongoing kerfuffle over Gonzalez’s "misstated" college credentials.
The healthcare giant confirmed last week that regulatory filings and company documents had mistakenly attributed to Gonzalez bachelor’s and master’s degrees, when the long-time Abbott executive never finished college.
"I have worked with and known Rick for nearly 30 years. He is one of the finest leaders, businessmen and individuals I have known," White wrote in a company email, which was obtained by the Chicago Sun-Times. "He has managed and led our business with integrity and commitment to our patients, our employees and our shareholders."
"The board and I are fully confident in him and his ability to lead AbbVie," White added.
Read more
Giffen Solutions welcomes new CEO
Electronic health communications company Giffen Solutions, Inc., creator of mobile medical apps MedXCom and MedXCom Patient, named Harry Carr as the new CEO.
Carr previously was the CEO of Simpler Networks Inc., and also worked at Lucent Technologies, Yurie Systems and AT&T.
Read more
PositiveID Corp. CFO leaves
Healthcare and medical device company PositiveID Corp. terminated the employment of CFO Bryan Happ and named the company’s chairman and CEO William Caragol as the company’s acting chief financial officer, according to a regulatory filing.
Happ joined the company in 2011, prior to which he worked at Green Bullion Financial Services, Cogdell Spencer Inc., NationsHealth Inc., Marshall Erdman & Associates, PricewaterhouseCoopers and Ernst & Young LLP.
Read more
